SCHEDULE 13D

Company

NextCure, Inc.

Filed

May 21, 2019

Accession Number

0000947871-19-000387

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →